~71 spots leftby Apr 2026

Financial Incentives + Nurse Coaching for Type 2 Diabetes

(FINANCE-DM Trial)

Recruiting in Palo Alto (17 mi)
LE
Overseen byLeonard Egede, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: State University of New York at Buffalo
No Placebo Group

Trial Summary

What is the purpose of this trial?

The objective of this protocol is to answer the questions: 1) Are financial incentives layered upon nurse education and home telemonitoring superior to nurse education and home telemonitoring alone in improving metabolic control long term? 2) Are the effects of financial incentives on metabolic control sustained once the incentives are withdrawn? and 3) Are financial incentives efficacious within and consistent across racial/ethnic groups? This study provides a unique opportunity to address these gaps in the literature. Investigators propose a randomized controlled trial to test the efficacy of a Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM) intervention comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives; compared to an active control group (nurse education and home telemonitoring alone). The study also will evaluate whether intervention effects are sustained 6 months after the financial incentives are withdrawn (i.e. 18 months post randomization); and whether the intervention is differentially efficacious across racial/ethnic groups.

Research Team

LE

Leonard Egede, MD

Principal Investigator

Medical College of Wisconsin

Eligibility Criteria

This trial is for adults over 21 with Type 2 Diabetes, specifically those who have not managed to control their blood sugar well (HbA1c >=8%). Participants must speak English, be willing to use a home monitoring system for a year, and have access to phone or internet. It's not open to those with life expectancies under 18 months, other diabetes trial participants, significant dementia, substance abuse issues, or acute mental disorders.

Inclusion Criteria

Ability to communicate in English
Subjects must have access to a landline, Ethernet or cellphone for FORA data uploads for the study period
I have type 2 diabetes with an HbA1c level of 8% or higher.
See 3 more

Exclusion Criteria

You are currently involved in other studies for diabetes.
You have serious memory and thinking problems that affect your daily life.
You are currently experiencing severe mental health issues or a sudden change in mental condition.
See 2 more

Treatment Details

Interventions

  • Active Comparator (Behavioral)
  • FINANCE-DM (Behavioral)
Trial OverviewThe FINANCE-DM study is testing if financial rewards can boost the effectiveness of nurse education and home telemonitoring in managing Type 2 Diabetes. Half the patients will receive money incentives on top of this care; the other half won't. Researchers want to see if these benefits last even after stopping the payments and if they work equally well across different racial groups.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: FINANCE-DM InterventionExperimental Treatment1 Intervention
The FINANCE-DM intervention is comprised of: 1) nurse education, 2) home telemonitoring, and 3) structured financial incentives.
Group II: TIDES InterventionActive Control1 Intervention
Patients randomized to the active comparator group will be assigned the FORA 2-in-1 Telehealth System. A nurse educator will review the glucose and BP readings and use them to tailor and reinforce behavior change.

Find a Clinic Near You

Who Is Running the Clinical Trial?

State University of New York at Buffalo

Lead Sponsor

Trials
279
Recruited
52,600+
Dr. Jonathan Slonin profile image

Dr. Jonathan Slonin

State University of New York at Buffalo

Chief Medical Officer since 2020

MD from University of Miami, MBA from George Washington University

Stacy Knapper profile image

Stacy Knapper

State University of New York at Buffalo

Chief Executive Officer since 2023

BSEE from University of Puerto Rico-Mayagüez, MS in Management from Rensselaer Polytechnic Institute

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+
Dr. Joseph E. Kerschner profile image

Dr. Joseph E. Kerschner

Medical College of Wisconsin

Chief Medical Officer since 2011

MD, specific institution not identified

Dr. John R. Raymond, Sr. profile image

Dr. John R. Raymond, Sr.

Medical College of Wisconsin

Chief Executive Officer since 2010

MD from the Medical University of South Carolina